Search for: "Patent Docs"
Results 881 - 900
of 1,613
Sorted by Relevance
|
Sort by Date
9 Dec 2009, 3:59 pm
(Patent Docs) Rozerem (Ramelteon) – US: Complaint filed in Delaware: Infringement of US patent following a Paragraph IV challenge: Takeda Pharmaceutical Co. [read post]
14 Oct 2008, 11:11 am
You can separately subscribe to the IP Think Tank Global week in Review, which includes IP Think Tank Events, at the Subscribe page: [duncanbucknell.com] Events 20-21 October: Practising Law Institute (PLI) seminar on understanding the IP license 2008 – Chicago, New York: (Philip Brooks), 22-24 October: ‘IP Pharma Europe Summit’ – Montreux, Switzerland: (Generic Pharmaceuticals and IP) 22-24 October: Europe INNOVA Conference 2008 – Lyon,… [read post]
18 Sep 2007, 1:23 pm
Patent Docs was on the call too. [read post]
13 Aug 2020, 5:35 am
You have to get DOC approval for almost anything like that. [read post]
19 Jan 2010, 12:00 am
Check out the court’s opinion and the comments from Patent Docs on the Navinta case and let us know what you think. [read post]
8 May 2009, 8:00 am
(Property intangible) US: Supreme Court rules 9-0 that CAFC has jurisdiction to review case remanded by district court to state court: Carlsbad Technology Inc v HIF Bio, Inc et al (Managing Intellectual Property) (Patently-O) US: Anticipation by a laundry list of prophetic DNA sequences: In re Gleave (Holman's Biotech IP Blog) US: Reverse payment settlements and biotechnology (Holman's Biotech IP Blog) US: Biogen seeks review and correction of patent term adjustment… [read post]
29 Apr 2008, 8:52 am
Patent and Trademark Office (USPTO) announced that it had signed a memorandum of understanding with the European Patent Office (EPO) and the Japan Patent Office (JPO) addressing the global workload challenges arising from the growth and complexity of patent applications worldwide. [read post]
25 Jan 2011, 10:58 pm
Cephalon (Patently-O) Seroquel (Quetiapine) – UK: Teva launches High Court action to revoke AstraZeneca’s European patent (IP Factor) Synagis – US: PDL BioPharma Synagis patent invalidated: Medimmune v PDL BioPharma (Patent Docs) Tarka (Trandolapril, Verapamil) – US: Glenmark loses jury verdict in DNJ over Tarka (IPBiz) Wechol (Colesevelam) – US: Watson confirms Welchol oral suspension patent challenge (SmartBrief) [read post]
3 Nov 2008, 1:37 pm
You can separately subscribe to the IP Think Tank Global week in Review, which includes IP Think Tank Events, at the Subscribe page: [duncanbucknell.com] Pharma 11-13 November: Visiongain’s 4th biosimilars conference – Philadelphia: (Patent Docs), 12 November: BNA Legal & Business Edge conference ‘Pharmaceutical patent laws: a prescription for success in challenging times’ – Arlington, Virginia: (Orange… [read post]
2 Sep 2009, 5:57 pm
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Glivec (Imatinib) – India: Novartis persists in challenge to Indian patent law; Justice Katju recuses himself (Spicy IP) (Intellectual Property Watch) Ultracet (Tramadol/Acetaminophen) – US: CAFC vacates Ultracet obviousness decision: Ortho-McNeil Pharmaceutical, Inc v Teva Pharmaceuticals (not precedential)… [read post]
22 Apr 2010, 3:51 am
(Patent Docs) Xibrom (Bromfenac) - US: District Court W D Tennessee: False marking complaint: Baker v Bausch & Lomb, Inc (Patent Docs) Zyprexa (Olanzapine) – Canada: Court denies Novopharm’s motion for Mareva injunction: Lilly v Novopharm (Pharmacapsules) [read post]
10 Mar 2008, 8:26 am
RELATED READING: Patent Docs Pfizer press release Reuters Wall St. [read post]
22 Oct 2015, 12:46 pm
Docs: Kroger’s Motion to Stay, Nexuscard Opposition The CBM petition challenges the patent claims under 35 U.S.C. 101 — arguing that they lack subject matter eligibility under Alice Corp and that the patent qualifies for CBM review because it claim a method for using a financial product and is not a technological invention. [read post]
2 Nov 2011, 2:00 am
(Patent Baristas) US: Life Sciences venture funding drops in third quarter (Patent Docs) USPTO announces agenda for next BCP Customer Partnership Meeting (Patent Docs) US: Mayo v. [read post]
1 Nov 2011, 6:00 am
Department of Commerce(DOC) and theU.S. [read post]
5 Dec 2008, 1:00 pm
You can separately subscribe to the Pharma & Biotech Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: European Commission issues preliminary report on its inquiry into competition in the pharmaceutical sector (IPKat) (Copyfight) (IAM) (Managing Intellectual Property) (Law360)… [read post]
22 Dec 2010, 1:20 pm
Consequently, as already expressed by the Competitive Council in the meeting of 4 December 2009 (EU doc 111744 "Conclusions on an enhanced patent system in Europe"), "the European and EU Patents Court could form the basis of [...] [read post]
17 Aug 2013, 9:21 pm
Intervenor Defendant United States Patent and Trademark Office’s (“USPTO”) Motion for Summary Judgment on its Fair Use Defense and Counterclaim (Doc. [read post]
4 Nov 2009, 4:03 am
(Spicy IP) India approaches WTO as yet another seizure takes place (Spicy IP) UK: IPO issues SPC guide (The SPC Blog) US: Follow-on biologics data exclusivity debate scorecard (Part 1 – Patent Docs) (Part II – Patent Docs) (Part III – Patent Docs) US: 12 Senators write in support of 12-year data exclusivity period (Patent Docs) US: Affordable Health Care for America Act introduced in House; includes… [read post]
4 Nov 2009, 4:03 am
(Spicy IP) India approaches WTO as yet another seizure takes place (Spicy IP) UK: IPO issues SPC guide (The SPC Blog) US: Follow-on biologics data exclusivity debate scorecard (Part 1 - Patent Docs) (Part II - Patent Docs) (Part III - Patent Docs) US: 12 Senators write in support of 12-year data exclusivity period (Patent Docs) US: Affordable Health Care for America Act introduced in House; includes biosimilar licensure pathway… [read post]
